EPO Patents = 2

Trademarks = 1

Forward Citations = 6

Loading Chart...

3 inventors (with patents filed for the assignee):

Michael R Loken (5 out of 16 patents)

Sanjaya N Joshi (3 out of 3 patents)

Andrew P Voigt (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 12046331 - System, method, and article for detecting abnormal cells using multi-dimensional analysis (2024-07-23),

2. 11639936 - System, method, and article for detecting abnormal cells using multi-dimensional analysis (2023-05-02),

3. 9880155 - System, method, and article for detecting abnormal cells using multi-dimensional analysis (2018-01-30),

4. 8630833 - System, method, and article for detecting abnormal cells using multi-dimensional analysis (2014-01-14),

5. 7045295 - Method for collecting purified cells (2006-05-16),

Company Overview

Hematologics, Inc. is a leading biotechnology company specializing in the research and development of innovative therapies for hematologic disorders. With a focus on cutting-edge technology and groundbreaking research, Hematologics is dedicated to improving the lives of patients worldwide. Their team of experts is committed to advancing the field of hematology through their pioneering work in drug discovery and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#356 in Seattle, WA

#1,240 in Washington

#51,620 in US

Seattle, WA, United States of America

Hematologics, Inc.

Forward Citations = 6

3 inventors:

Michael R Loken (5 out of 16 patents)

Sanjaya N Joshi (3 out of 3 patents)

Andrew P Voigt (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hematologics, Inc.. Retrieved from https://idiyas.com/company/hematologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]